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Abstract
Background—Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia akari are the most common 
causes of spotted fever group rickettsioses indigenous to the United States. Infected patients 
characteristically present with a maculopapular rash, often accompanied by an inoculation eschar. 
Skin biopsy specimens are often obtained from these lesions for diagnostic evaluation. However, a 
species-specific diagnosis is achieved infrequently from pathologic specimens because 
immunohistochemical stains do not differentiate among the causative agents of spotted fever 
group rickettsiae, and existing polymerase chain reaction (PCR) assays generally target large gene 
segments that may be difficult or impossible to obtain from formalin-fixed tissues.
Methods—This work describes the development and evaluation of a multiplex real-time PCR 
assay for the detection of these 3 Rickettsia species from formalin-fixed, paraffin-embedded 
(FFPE) skin biopsy specimens.
Results—The multiplex PCR assay was specific at discriminating each species from FFPE 
controls of unrelated bacterial, viral, protozoan, and fungal pathogens that cause skin lesions, as 
well as other closely related spotted fever group Rickettsia species.
Conclusions—This multiplex real-time PCR demonstrates greater sensitivity than nested PCR 
assays in FFPE tissues and provides an effective method to specifically identify cases of Rocky 
Mountain spotted fever, rickettsialpox, and R. parkeri rickettsiosis by using skin biopsy 
specimens.
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Spotted fever group Rickettsia (SFGR) species are a large and diverse assemblage of 
obligately intracellular, Gram-negative bacteria that reside in fleas, ticks, and mites. At least 
9 named SFGR species are endemic to the United States, including several known 
pathogens. However, most indigenous spotted fever group (SFG) rickettsioses are caused by 
Rickettsia rickettsii, Rickettsia akari, or Rickettsia parkeri, the etiologic agents of Rocky 
Mountain spotted fever (RMSF), rickettsialpox, and R. parkeri rickettsiosis, respectively [1]. 
Each of these infections is characterized by fever and a generalized exanthem, and skin 
biopsy specimens are often obtained to establish a presumptive diagnosis.
Rickettsia rickettsii is transmitted by several tick species, including Dermacentor variabilis, 
Dermacentor andersoni, and Rhipicephalus sanguineus. Several hundred to several 
thousand cases of RMSF are reported annually in the United States, predominantly from the 
central and southeastern states [2]. RMSF is the most severe SFG rickettsiosis; the case-
fatality rate of untreated infections can be >20%. A maculopapular or petechial rash is 
identified on most patients, but an inoculation eschar is rarely described [3–5]. Rickettsia 
akari is transmitted to humans from the bite of the house mouse mite (Liponyssoides 
sanguineus) [6]. Rickettsialpox is milder than RMSF and is typically associated with an 
inoculation eschar and a maculopapular rash that may be vesicular. In the United States, 
rickettsialpox exists as an urban zoonosis, and almost every documented US case has 
originated from a large metropolitan center [7]. The intentional release of Bacillus anthracis 
as a weapon of bioterrorism in 2001 elevated physician awareness of eschar-associated 
illnesses, including rickettsialpox [8]. Rickettsia parkeri was first identified as a cause of 
disease in humans in 2004 [9]. The Gulf Coast tick (Amblyomma maculatum) is the vector 
of R. parkeri and is distributed throughout much of the southeastern and mid-Atlantic 
United States [10]. This moderately severe illness shares features with RMSF and 
rickettsialpox, namely, the occurrence of 1 or more inoculation eschars, and a 
maculopapular rash, occasionally with vesicular or petechial components [9].
The sympatric distribution of the tick vectors and Rickettsia species, and the clinical and 
histological similarities of 1 or more of the cutaneous manifestations of RMSF, R. parkeri 
rickettsiosis and rickettsialpox (Figures 1 and 2), necessitate the use of advanced methods to 
confirm and distinguish these infections. In addition, various other viral, bacterial, fungal, or 
protozoan pathogens may cause eschar or rash lesions that are clinically or histologically 
similar to those caused by SFGR [10, 11]. Immunohistochemical staining techniques are 
useful to confirm SFG rickettsioses; however, these assays are not species specific [7,9]. 
Species-specific identification of the diseases is achieved infrequently from formalin-fixed, 
paraffin-embedded (FFPE) specimens [12], because relatively large segments of particular 
gene targets are used conventionally to establish a molecular diagnosis from blood or fresh 
tissues [13]. Species-specific confirmation from FFPE skin biopsy specimens is particularly 
challenging because formalin causes nucleic acid fragmentation that characteristically limits 
the size of successful polymerase chain reaction (PCR) amplicons [12], and skin biopsies 
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typically provide relatively small amounts of pathogen DNA for molecular analysis. This 
work was initiated to develop a reliable real-time PCR assay to amplify small but specific 
DNA fragments of 3 of the most frequently encountered pathogenic SFGR in the United 
States from FFPE skin biopsy specimens.
MATERIALS AND METHODS
Selection and Preparation of Controls
FFPE control blocks were prepared from Vero E6 cells infected separately with 10 
Rickettsia species that included (1) recognized pathogens endemic to the United States (R. 
rickettsii, R. parkeri, R. akari, and Rickettsia felis); (2) pathogenic species associated with 
international travel (Rickettsia australis, Rickettsia africae, Rickettsia conorii, Rickettsia 
sibirica, and Rickettsia massiliae), and (3) a Rickettsia species of undetermined 
pathogenicity (Candidatus “Rickettsia amblyommii”) [14] (Table 1). Additional controls 
included FFPE blocks containing cells or tissues infected with unrelated viral, bacterial, 
protozoan, and fungal pathogens that may cause cutaneous lesions, including human 
herpesviruses 1, 2, and 3, orf virus, Bacillus anthracis, Francisella tularensis, Yersinia 
pestis, Pseudomonas aeruginosa, Staphylococcus aureus, Capnocytophaga canimorsus, 
Neisseria meningitidis, Ehrlichia chaffeensis, Anaplasma phagocytophilum, Burkholderia 
pseudomallei, Leptospira species, Salmonella typhi, Sporothrix schenckii, and Leishmania 
mexicana mexicana.
Case-patient specimens for evaluation included 31 FFPE skin biopsy specimens submitted to 
the Infectious Diseases Pathology Branch at the Centers for Disease Control and Prevention 
during the years 2001 through 2013 that tested positive for infection with a SFGR species by 
immunohistochemical (IHC) staining. Among this set of specimens included 16 for which a 
species-specific diagnosis was available by culture or nested ompA gene PCR evaluation of 
fresh tissue, blood, or another specimen [18]. The remaining 15 samples were selected based 
on clinical and epidemiological features that were compatible with a presumptive diagnosis 
of RMSF, R. parkeri rickettsiosis, or rickettsialpox (Table 2).
DNA Extraction
Four 16-μm sections were cut from each paraffin block and placed in a microcentrifuge tube. 
The sections were deparaffinized with xylene and washed twice with absolute ethanol. 
Tissues were incubated overnight at 56°C in 180 μL Buffer ATL and 20 μL proteinase K 
(Qiagen, Valencia, California). Extraction of the supernatant was completed using a Qiagen 
QIAamp DNA Micro Kit and the manufacturer’s “Tissues” protocol, with a final elution 
volume of 50 μL.
Molecular Assays
Primer and probe sequences for real-time PCR are listed in Table 3. For detection of SFGR, 
real-time PCR primers targeting the citrate synthase gene (gltA) were used [19]. The 
reaction consisted of 12.5 μL of Qiagen QuantiTect Multiplex PCR Master Mix, 0.4 μM of 
each of the forward and reverse primers, 0.2 μM of the probe, and 2.5 μL of DNA extract in 
a 25-μL volume. Cycling conditions consisted of 1 cycle of 95°C for 15 minutes, and 45 
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cycles of 95°C for 60 seconds and 60°C for 60 seconds using an Agilent (Santa Clara, 
California) Mx3005P real-time thermal cycler.
Primers and probes targeting a hypothetical protein gene of the R. rickettsii genome [20] and 
the ompB genes of R. parkeri [21] and R. akari were multiplexed into a single tube real-time 
assay. Reactions were comprised of 12.5 μL of Qiagen QuantiTect Multiplex PCR Master 
Mix, 0.2 μM of each of the forward and reverse primers and probes, and 2.5 μL of DNA 
extract in a 25-μL volume. Cycling conditions consisted of 1 cycle of 95°C for 15 minutes, 
and 45 cycles of 94°C for 60 seconds and 60°C for 90 seconds using an Agilent Mx3005P 
real-time thermal cycler. All PCR reactions included appropriate positive and negative 
controls, and samples were considered positive if the cycle threshold value was ≤40 for each 
of the respective targets.
Conventional nested PCR assays to the ompA gene and the 17 kDa antigen gene have long 
been considered the molecular reference standard for SFGR detection and were used in this 
work as a comparison to the real-time PCR assays. The ompA PCR was performed as 
previously described [18]. Heminested PCR to the 17 kDa antigen gene was performed 
using primers TZ15 and TZ16 [15] in the primary stage, and a Roche (Indianapolis, Indiana) 
High Fidelity PCR Master Kit with final primer concentrations of 300 nmol and 2.5 μL 
DNA extract in a 25-μL reaction volume. Reactions were denatured at 94°C for 2 minutes; 
then subjected to 40 cycles of 94°C for 15 seconds, 55°C for 30 seconds, and 72°C for 45 
seconds; and a final extension at 72°C for 5 minutes. The heminested stage produced a 218-
bp amplicon with primers TZ-FN (5′-TTG TBG GAG TAG GTG TAG) and TZ16, and the 
reaction used 1 μL of the primary PCR reaction and the same cycling conditions as above, 
except the total number of cycles was reduced to 30.
Amplicons from the ompA and 17 kDa antigen PCR assays were agarose gel-purified using 
a Qiagen QiaQuick Gel Extraction Kit. Cycle sequencing of the eluates was performed using 
Quick Start DTCS Master Mix (Beckman Coulter, Indianapolis, Indiana). Reactions were 
purified using a Qiagen DyeEx 2.0 Spin Kit, concentrated by vacuum centrifugation, 
suspended in 35 μL of Sample Loading Solution (Beckman Coulter), and placed on a 
GenomeLab GeXP (Beckman Coulter) for sequencing. Consensus nucleotide sequences 
were analyzed using CLC Main Workbench (Cambridge, Massachusetts) and the National 
Center for Biotechnology Information’s Basic Local Alignment Search Tool program 
(http://blast.ncbi.nlm.nih.gov).
RESULTS
The multiplex PCR assay correctly identified all cell controls for R. rickettsii, R. parkeri, 
and R. akari. No false-positive reactions were detected with any of the infected cell culture 
controls containing other Rickettsia species or other viral, bacterial, fungal, or protozoan 
pathogens (Table 1). As expected, DNA extracts from R. massiliae, R. felis, and R. australis 
did not produce amplicons with the ompA primer set [16, 17, 22], and DNA extracted from 
R. akari did not produce amplicons with the ompA [17] or 17 kDa antigen primer set due to 
mismatches between the nucleotide sequences.
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DNA extracted from FFPE skin biopsy specimens from 6 cases of culture-confirmed or 
ompA nested PCR–confirmed [18] R. parkeri infection were tested with the real-time PCR 
assay; all 6 cases were positive for R. parkeri and negative for R. rickettsii and R. akari. 
Three confirmed cases of fatal RMSF and 2 confirmed cases of rickettsialpox were positive 
for their respective targets and negative for the targets of the 2 other Rickettsia species. 
DNA extracts from FFPE biopsies obtained from 5 patients with PCR-confirmed African 
tick bite fever and from 1 patient with PCR-confirmed infection with Rickettsia 364D [23] 
were positive when tested for the Rickettsia citrate synthase gene (gltA) [19], but negative 
for R. parkeri, R. rickettsii, and R. akari when tested by the multiplex real-time PCR assay.
Several cases of suspected SFGR infection were also analyzed to determine a causative 
species. Each of the suspected cases was negative by ompA and 17 kDa antigen gene PCR. 
Based on their geographical origin and clinical characteristics, the evaluation included 10 
suspected cases of rickettsialpox from New York City, 4 suspected cases of R. parkeri 
rickettsiosis from Maryland, South Carolina, Texas, and Virginia, and 1 suspected case of 
fatal RMSF from Mexico. All 15 suspected cases were positive by gltA real-time PCR, 
indicating the presence of rickettsial DNA. The suspected RMSF case was positive for the 
R. rickettsii hypothetical protein target only. All suspected rickettsialpox cases were positive 
only for the R. akari ompB gene in the real-time assay. Of the 4 suspected cases of R. 
parkeri rickettsiosis, only 3 were positive by the real-time assay for the R. parkeri ompB 
gene. The fourth suspected case was instead positive for the R. akari ompB gene.
DISCUSSION
This study is the first to utilize a multiplex real-time PCR assay for the detection of R. 
rickettsii, R. akari, and R. parkeri in FFPE skin biopsy specimens. From culture- and PCR-
confirmed cases, R. parkeri, R. rickettsii, and R. akari were successfully identified. We were 
able to determine a causative species using the real-time PCR assay in biopsies from several 
suspected cases of IHC-positive SFGR infection. One case of SFG rickettsiosis in a 76-year-
old woman from Maryland was initially suspected to be caused by R. parkeri and was 
unexpectedly discovered to be positive for R. akari. Accurate identification of the infecting 
Rickettsia species is critically important to establish valid distributions and clinical 
consequences associated with the SFG rickettsioses [24], and there are possibly many 
examples of incorrect associations based on nonspecific assays [25].
There are certain limitations to this method. Immunohistochemical analysis of skin biopsy 
specimens reveals that rickettsial antigens are not uniformly distributed throughout the 
tissue. Whereas one tissue section may contain abundant antigen and nucleic acid, a tissue 
section cut from deeper into the FFPE block may have markedly less rickettsial nucleic acid 
available for analysis [26]. Exposure of the FFPE block to air or prolonged fixation of the 
tissue specimen in formalin can also affect the quality and quantity of nucleic acid available 
for amplification [27]. The timing of the biopsy procedure during the course of infection and 
the interval from administration of an appropriate antibiotic (ie, doxycycline) prior to biopsy 
may also affect the quantity of amplifiable nucleic acids in the biopsy sample [26]. This 
multiplex assay confirmed the infecting SFG Rickettsia species in 15 case-patients that 
would not have been known otherwise; nonetheless, infections caused by other Rickettsia 
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species endemic to the United States, such as Rickettsia species 364D and R. felis [23, 28], 
and those associated with foreign travel, such as R. africae [29], are not specifically 
identified by this multiplex assay, reflecting a need for development of additional molecular 
methods to confirm rickettsioses from FFPE skin biopsy specimens.
Formalin fixation of skin biopsy specimens allows for histologic and IHC analysis, but due 
to cross-linking and fragmentation of nucleic acids, performing PCR on FFPE samples can 
be difficult due to the large amplicon sizes and nested PCR protocols needed to obtain 
sufficient sequencing data for Rickettsia species differentiation. These are also time-
consuming processes. By developing this multiplex real-time PCR assay, a species-specific 
diagnosis can be obtained in <3 hours, as compared to the ≥8 hours needed to amplify and 
sequence products obtained by conventional nested PCR.
This multiplex real-time PCR assay was developed to evaluate nucleic acids extracted from 
FFPE skin biopsy specimens, but it is also possible that these methods can be effectively 
adapted for use on a variety of other specimen types. Detection of rickettsial DNA has been 
increasingly reported using swabs of eschars [30–33], and quantitative PCR of swab 
material collected as late as 2 weeks after the start of antibiotic therapy may provide a 
confirmatory result in some cases [32]. We have also successfully applied this multiplex 
assay to obtain species-specific diagnoses from other types of FFPE tissues (unpublished 
data).
In conclusion, this multiplex real-time PCR establishes a rapid method to distinguish these 
infections from other infectious causes of eschar- and rash-associated illnesses, and can 
provide more accurate information on the distribution and clinical characteristics of these 
rickettsioses by establishing a species-specific diagnosis.
Acknowledgments
We thank Maureen G. Metcalfe for sectioning of FFPE blocks and for review of the manuscript.
References
1. Wood H, Artsob H. Spotted fever group rickettsiae: a brief review and a Canadian perspective. 
Zoonoses Public Health. 2012; 59(suppl 2):65–79. [PubMed: 22958251] 
2. Openshaw JJ, Swerdlow DL, Krebs JW, et al. Rocky Mountain spotted fever in the United States, 
2000–2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg. 2010; 83:174–
82. [PubMed: 20595498] 
3. Arguello AP, Hun L, Rivera P, Taylor L. A fatal urban case of Rocky Mountain spotted fever 
presenting an eschar in San Jose, Costa Rica. Am J Trop Med Hyg. 2012; 87:345–8. [PubMed: 
22855769] 
4. Chen LF, Sexton DJ. What’s new in Rocky Mountain spotted fever? Infect Dis Clin North Am. 
2008; 22:415–32. [PubMed: 18755382] 
5. Walker DH, Gay RM, Valdes-Dapena M. The occurrence of eschars in Rocky Mountain spotted 
fever. J Am Acad Dermatol. 1981; 4:571–6. [PubMed: 7240465] 
6. Huebner RJ, Jellison WL, Armstrong C. Rickettsialpox—a newly recognized rickettsial disease. V. 
Recovery of Rickettsia akari from a house mouse (Mus musculus). Public Health Rep. 1947; 
62:777–80. [PubMed: 20342271] 
7. Paddock CD, Zaki SR, Koss T, et al. Rickettsialpox in New York City: a persistent urban zoonosis. 
Ann N Y Acad Sci. 2003; 990:36–44. [PubMed: 12860597] 
Denison et al. Page 6













8. Koss T, Carter EL, Grossman ME, et al. Increased detection of rickettsialpox in a New York City 
hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid 
confirmation of cases in an era of bioterrorism. Arch Dermatol. 2003; 139:1545–52. [PubMed: 
14676069] 
9. Paddock CD, Finley RW, Wright CS, et al. Rickettsia parkeri rickettsiosis and its clinical distinction 
from Rocky Mountain spotted fever. Clin Infect Dis. 2008; 47:1188–96. [PubMed: 18808353] 
10. Teel PD, Ketchum HR, Mock DE, Wright RE, Strey OF. The Gulf Coast tick: a review of the life 
history, ecology, distribution, and emergence as an arthropod of medical and veterinary 
importance. J Med Entomol. 2010; 47:707–22. [PubMed: 20939363] 
11. Kao GF, Evancho CD, Ioffe O, Lowitt MH, Dumler JS. Cutaneous histopathology of Rocky 
Mountain spotted fever. J Cutan Pathol. 1997; 24:604–10. [PubMed: 9449487] 
12. Cragun WC, Bartlett BL, Ellis MW, et al. The expanding spectrum of eschar-associated 
rickettsioses in the United States. Arch Dermatol. 2010; 146:641–8. [PubMed: 20404224] 
13. Fournier PE, Dumler JS, Greub G, Zhang J, Wu Y, Raoult D. Gene sequence-based criteria for 
identification of new rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov J 
Clin Microbiol. 2003; 41:5456–65. [PubMed: 14662925] 
14. Parola P, Paddock CD, Socolovschi C, et al. Update on tick-borne rickettsioses around the world: a 
geographic approach. Clin Microbiol Rev. 2013; 26:657–702. [PubMed: 24092850] 
15. Tzianabos T, Anderson BE, McDade JE. Detection of Rickettsia rickettsii DNA in clinical 
specimens by using polymerase chain reaction technology. J Clin Microbiol. 1989; 27:2866–8. 
[PubMed: 2512328] 
16. Fornadel CM, Smith JD, Zawada SE, Arias JR, Norris DE. Detection of Rickettsia massiliae in 
Rhipicephalus sanguineus from the Eastern United States. Vector Borne Zoonotic Dis. 2013; 
13:67–9. [PubMed: 23199270] 
17. Fournier PE, Roux V, Raoult D. Phylogenetic analysis of spotted fever group rickettsiae by study 
of the outer surface protein rOmpA. Int J Syst Bacteriol. 1998; 48(pt 3):839–49. [PubMed: 
9734038] 
18. Sumner JW, Durden LA, Goddard J, et al. Gulf Coast ticks (Amblyomma maculatum) and 
Rickettsia parkeri, United States. Emerg Infect Dis. 2007; 13:751–3. [PubMed: 17553257] 
19. Stenos J, Graves SR, Unsworth NB. A highly sensitive and specific real-time PCR assay for the 
detection of spotted fever and typhus group Rickettsiae. Am J Trop Med Hyg. 2005; 73:1083–5. 
[PubMed: 16354816] 
20. Kato CY, Chung IH, Robinson LK, Austin AL, Dasch GA, Massung RF. Assessment of real-time 
PCR assay for detection of Rickettsia spp. and Rickettsia rickettsii in banked clinical samples. J 
Clin Microbiol. 2013; 51:314–7. [PubMed: 23135935] 
21. Jiang J, Stromdahl EY, Richards AL. Detection of Rickettsia parkeri and Candidatus Rickettsia 
andeanae in Amblyomma maculatum Gulf Coast ticks collected from humans in the United States. 
Vector Borne Zoonotic Dis. 2012; 12:175–82. [PubMed: 22022815] 
22. Znazen A, Khrouf F, Elleuch N, et al. Multispacer typing of Rickettsia isolates from humans and 
ticks in Tunisia revealing new genotypes. Parasit Vectors. 2013; 6:367. [PubMed: 24380581] 
23. Shapiro MR, Fritz CL, Tait K, et al. Rickettsia 364D: a newly recognized cause of eschar-
associated illness in California. Clin Infect Dis. 2010; 50:541–8. [PubMed: 20073993] 
24. Paddock CD. Perspectives on the laboratory diagnosis of rickettsial diseases in the 21st century. 
Acta Méd Costarric. 2013; 55:13–24.
25. Krusell A, Comer JA, Sexton DJ. Rickettsialpox in North Carolina: a case report. Emerg Infect 
Dis. 2002; 8:727–8. [PubMed: 12095443] 
26. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial 
diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis—United States: a 
practical guide for physicians and other health-care and public health professionals. MMWR 
Recomm Rep. 2006; 55:1–27.
27. Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and 
integrity of nucleic acids. Am J Pathol. 2002; 161:1961–71. [PubMed: 12466110] 
Denison et al. Page 7













28. Schriefer ME, Sacci JB Jr, Dumler JS, Bullen MG, Azad AF. Identification of a novel rickettsial 
infection in a patient diagnosed with murine typhus. J Clin Microbiol. 1994; 32:949–54. [PubMed: 
8027348] 
29. McQuiston JH, Paddock CD, Singleton J Jr, Wheeling JT, Zaki SR, Childs JE. Imported spotted 
fever rickettsioses in United States travelers returning from Africa: a summary of cases confirmed 
by laboratory testing at the Centers for Disease Control and Prevention, 1999–2002. Am J Trop 
Med Hyg. 2004; 70:98–101. [PubMed: 14971705] 
30. Bechah Y, Socolovschi C, Raoult D. Identification of rickettsial infections by using cutaneous 
swab specimens and PCR. Emerg Infect Dis. 2011; 17:83–6. [PubMed: 21192860] 
31. Mouffok N, Socolovschi C, Benabdellah A, Renvoise A, Parola P, Raoult D. Diagnosis of 
rickettsioses from eschar swab samples, Algeria. Emerg Infect Dis. 2011; 17:1968–9. [PubMed: 
22000389] 
32. Myers T, Lalani T, Dent M, et al. Detecting Rickettsia parkeri infection from eschar swab 
specimens. Emerg Infect Dis. 2013; 19:778–80. [PubMed: 23647926] 
33. Wang JM, Hudson BJ, Watts MR, et al. Diagnosis of Queensland tick typhus and African tick bite 
fever by PCR of lesion swabs. Emerg Infect Dis. 2009; 15:963–5. [PubMed: 19523304] 
Denison et al. Page 8














Clinical and histological resemblance between the inoculation eschar of Rickettsia parkeri 
rickettsiosis (A and C) and rickettsialpox (B and D). Clinically, both lesions are 
characterized by a 0.5- to 1.5-cm necrotic crust surrounded by an erythematous halo (A and 
B). Microscopically, these demonstrate indistinguishable features comprising necrosis of the 
epidermis and upper dermis, hemorrhage, and perivascular neutrophilic and 
lymphohistiocytic inflammatory cell infiltrates accompanied by occlusive fibrin thrombi (C 
and D) (hematoxylin and eosin stain, original magnifications ×25).
Denison et al. Page 9














Clinical and histological similarities among rashes of Rocky Mountain spotted fever (A and 
D), Rickettsia parkeri rickettsiosis (B and E), and rickettsialpox (C and F). Each infection 
may exhibit an erythematous maculopapular rash (A–C). The histological features of these 
rashes are often quite similar and are characterized predominantly by lymphohistiocytic 
perivascular inflammatory cell infiltrates (C–E) (hematoxylin and eosin stain, original 
magnifications ×25).
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Table 3
Targets and Primer and Probe Sequences Used in This Study
Target 5′ to 3′ Sequence Reference
Rickettsia species citrate synthase (gltA) gene TCG CAA ATG TTC ACG GTA CTT T
TCG TGC ATT TCT TTC CAT TGT G
FAM-TGC AAT AGC AAG AAC CGT AGG CTG GAT G-BHQ1
[19]
R. rickettsii hypothetical protein gene AAA TCA ACG GAA GAG CAA AAC
CCC TCC ACT ACC TGC ATC AT
CY5-TCC TCT CCA ATC AGC GAT TC-BHQ3
[20]
R. parkeri ompB gene CAA ATG TTG CAG TTC CTC TAA ATG
AAA ACA AAC CGT TAA AAC TAC CG
FAM-CGC GAA ATT AAT ACC CTT ATG AGC AGC AGT CGC G-BHQ1
[21]
R. akari ompB gene GTG GTG CTG TTG CAG GTG G
TTG CTC CAC CGA GAG TTA ATG TT
HEX-CGG TGC TGG TAA TGC TGC ATT ACA CG-BHQ1
This study
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